JPWO2023058645A5 - - Google Patents

Info

Publication number
JPWO2023058645A5
JPWO2023058645A5 JP2023552896A JP2023552896A JPWO2023058645A5 JP WO2023058645 A5 JPWO2023058645 A5 JP WO2023058645A5 JP 2023552896 A JP2023552896 A JP 2023552896A JP 2023552896 A JP2023552896 A JP 2023552896A JP WO2023058645 A5 JPWO2023058645 A5 JP WO2023058645A5
Authority
JP
Japan
Prior art keywords
compound
scheme
crystal
carbon atoms
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023552896A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023058645A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/037098 external-priority patent/WO2023058645A1/ja
Publication of JPWO2023058645A1 publication Critical patent/JPWO2023058645A1/ja
Publication of JPWO2023058645A5 publication Critical patent/JPWO2023058645A5/ja
Pending legal-status Critical Current

Links

JP2023552896A 2021-10-05 2022-10-04 Pending JPWO2023058645A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021164171 2021-10-05
PCT/JP2022/037098 WO2023058645A1 (ja) 2021-10-05 2022-10-04 化合物又はその薬学的に許容される塩の製造方法

Publications (2)

Publication Number Publication Date
JPWO2023058645A1 JPWO2023058645A1 (https=) 2023-04-13
JPWO2023058645A5 true JPWO2023058645A5 (https=) 2025-10-14

Family

ID=85803498

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023552896A Pending JPWO2023058645A1 (https=) 2021-10-05 2022-10-04

Country Status (11)

Country Link
US (1) US20240262805A1 (https=)
EP (1) EP4414362A4 (https=)
JP (1) JPWO2023058645A1 (https=)
KR (1) KR20240073943A (https=)
CN (1) CN118055925A (https=)
AU (1) AU2022361862A1 (https=)
CA (1) CA3234498A1 (https=)
IL (1) IL311879A (https=)
MX (1) MX2024004049A (https=)
TW (1) TW202330490A (https=)
WO (1) WO2023058645A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116947658B (zh) * 2023-07-28 2025-10-28 南通华祥医药科技有限公司 一种1-氨基-2-甲基-2-丙醇的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3269772B1 (en) * 2015-03-10 2020-11-11 Unimatec Co., Ltd. Fluorine-containing boric acid/pvb composite
ES2856125T3 (es) 2016-02-05 2021-09-27 Ea Pharma Co Ltd Derivado de sulfonamida y composición farmacéutica que contiene la misma
TW201731824A (zh) * 2016-02-05 2017-09-16 Ea Pharma Co Ltd α4β7整合蛋白抑制劑
JP2019031449A (ja) * 2017-08-04 2019-02-28 Eaファーマ株式会社 スルホンアミド誘導体及びそれを含有する医薬組成物

Similar Documents

Publication Publication Date Title
JP5373996B2 (ja) サクサグリプチン中間体、サクサグリプチン多形及びそれらの調製方法
JP2009073859A (ja) 置換シクロペンタン誘導体の調製方法及びその新規結晶構造
EP3414256B1 (en) Purification process involving amine salt of obeticholic acid
CA2476022C (en) A process for preparing a phenylalanine derivative and intermediates thereof
JPH03176495A (ja) ドーパミン及びドーパミン誘導体の4―0―リン酸エステルの製造方法
CN101657437B (zh) 制备左西替利嗪及其中间体的新方法
JPWO2023058645A5 (https=)
JPS60105670A (ja) アミノチアゾリル酢酸の新規なオキシム誘導体
WO2019215759A1 (en) An improved process for preparation of midostaurin
JP2960790B2 (ja) 経口投与用セファロスポリン水和物結晶
JP2019023224A (ja) 2−アミノ−1,3−プロパンジオール化合物およびその塩の製造のための方法
JP6670744B2 (ja) ヒオデオキシコール酸ナトリウム(NaHDC)の多形形態およびその調製方法
CN101171251A (zh) 氨曲南的制备方法
JP2018528233A (ja) インドリン化合物および新規インドリン塩を製造するプロセス
HU185457B (en) Process for preparating cimetidine-z
JP2597206B2 (ja) カルボキシアルキル置換ヒドロキシルアミン類の製造方法
RU2024111997A (ru) Способ получения соединения или его фармацевтически приемлемой соли
JP2012509305A (ja) 結晶化ペンタサッカライド、これを得る方法、およびイドラパリナックスの調製のためのこの使用
JP2008505189A (ja) アズトレオナムの製造方法
CN1035005C (zh) 制备6-(3-二甲氨基丙酰基)福司可林的新方法
WO2011116491A1 (zh) 制备二苯乙醇酸去甲托品酯和其盐的方法及其中所用的中间体
RU2741389C1 (ru) Способ получения промежуточного соединения для синтеза лекарственного средства
US20060247427A1 (en) Process to obtain 6-O-methylerythromycin a (clarithromycin)_form II
WO2019098551A1 (ko) 의약품 합성용 중간체 화합물의 제조 방법
HUP0600347A2 (en) Process for the preparation of {2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one (ziprasidon) and the intermediate